Collectively, these findings may suggest a novel hypothesis that TIGIT may be a better IC to target in OAC than PD-1 to reinvigorate anti-tumour immunity but to also reduce the survival of OAC cells under the nutrient-deprived and hypoxic conditions of the hostile TME. This evidence concerns the gene TIGIT and neoplasm.